Apollo Hospitals Interim Dividend of ₹9 Record Date Tomorrow, February 15, 2025

Apollo Hospitals Enterprise Ltd’s Board of Directors has declared and approved an interim dividend of ₹9 per equity share at 180% of the face value of ₹5 each.

On February 13, 2025, Apollo Hospitals share price (NSE: APOLLOHOSP) opened at ₹6,372.25 and closed at ₹6,365.95, down by 0.13%. The stock price touched its day’s low at ₹6,344.45.

Apollo Hospitals Dividend Record Date

The company’s Board of Directors has declared an interim dividend of ₹9 per share (180% of the face value of ₹5 per share) for the financial year ending March 31, 2025. The dividend will be distributed from the company’s profits.

The record date for determining eligible shareholders is set for February 15, 2025. Shareholders whose names appear in the Register of Members/Beneficial Owners as of this date will receive the interim dividend. The payout is scheduled to be completed on or before February 28, 2025.

Apollo Hospitals Q3 FY 2025 Financial Highlights

In Q3 FY25, the company’s consolidated revenues rose 14% YoY to ₹5,527 crore. The consolidated EBITDA grew 24% YoY to ₹762 crore. Meanwhile, the consolidated PAT surged 52% YoY to ₹372 crore.

About Apollo Hospitals Enterprise Ltd

Founded in 1983 by Dr. Prathap C. Reddy, Apollo Hospitals was the country’s first corporate hospital, leading the private healthcare revolution. It stands as Asia’s leading integrated healthcare provider, with a strong presence across the healthcare ecosystem, including hospitals, pharmacies, primary care & diagnostic clinics, and various retail health models.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.